Robert Barrow

Robert Barrow

Chief Executive Officer at DEFINIUM THERAPEUTICS, INC.

Net worth: 52 M $ as of 30/06/2026

37 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Robert Barrow, CFA, is a Chief Executive Officer & Director at Definium Therapeutics, Inc. and an Owner at Jasper Biopharmaceutical Advisors LLC.
He is on the Board of Directors at Definium Therapeutics, Inc. Mr. Barrow was previously employed as a Director-Drug Development by Promega Corp., a Director-Drug Development & Discovery by Usona Institute, a Chief Financial Officer by Olatec Therapeutics LLC, and a Chief Operating Officer by Olatec Therapeutics LLC.
He received his undergraduate degree from Wake Forest University and a graduate degree from The Ohio State University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/06/2026 1,098,246 ( 1.01% ) 52 M $ 30/06/2026

Robert Barrow active positions

CompaniesPositionStart
DEFINIUM THERAPEUTICS, INC. Chief Executive Officer 09/06/2021
Jasper Biopharmaceutical Advisors LLC
Corporate Officer/Principal 01/01/2018

Former positions of Robert Barrow

CompaniesPositionEnd
Corporate Officer/Principal 01/07/2020
Corporate Officer/Principal 01/01/2020
Director of Finance/CFO 01/01/2018
Chief Operating Officer -
See the detail of Robert Barrow's experience

Training of Robert Barrow

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

2

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Jasper Biopharmaceutical Advisors LLC